|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.8200 EUR | +27.53% |
|
+24.78% | -49.05% |
| 07-13 | AB Science to Discontinue Three Masitinib-related Clinical Studies | MT |
| 07-10 | AB Science streamlines its portfolio and refocuses on two molecules |  |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | +0.26% | -1.56% | -0.95% | +13.42% | +21.92% | +58.84% | +22.22% | +69.77% | +100.96% | 317B | |
| +1.24% | +3.05% | +3.08% | +29.46% | +20.07% | +39.46% | -8.03% | -18.31% | +50.67% | 72.79B | |
| +0.43% | +0.37% | +5.21% | +26.90% | +24.21% | +37.46% | +97.10% | +106.80% | +696.85% | 9.91B | |
| +2.42% | -5.13% | -8.10% | +5.03% | -0.51% | -3.90% | -5.54% | -27.34% | +52.00% | 8.16B | |
| +2.76% | +8.47% | -4.87% | -17.42% | -34.19% | -26.39% | -14.85% | -35.69% | - | 4.51B | |
| +0.40% | +6.83% | +6.68% | -17.02% | -33.19% | -34.64% | +7.29% | +40.00% | +82.80% | 3.94B | |
| +2.46% | +2.71% | -18.26% | +14.73% | +27.63% | -17.02% | +21.19% | -33.80% | - | 3.71B | |
| +8.46% | +0.73% | -2.37% | -4.64% | -5.61% | +24.99% | +45.77% | +76.42% | +102.99% | 2.73B | |
| -0.19% | -0.38% | +1.66% | -11.79% | -12.84% | -2.51% | -3.33% | +73.30% | - | 2.24B | |
| +1.75% | -0.22% | -4.84% | -12.68% | -6.40% | -25.96% | +29.50% | -32.34% | - | 1.79B | |
| -0.91% | -0.11% | -2.58% | -9.38% | -13.96% | -23.50% | -16.52% | -9.85% | -42.07% | 1.73B | |
| -.--% | -.--% | - | - | - | - | - | - | - | 1.64B | |
| +0.31% | -4.49% | +22.59% | +51.32% | +171.85% | +212.08% | +1,602.59% | +680.48% | - | 1.26B | |
| -0.03% | +6.82% | -11.52% | -28.98% | -16.36% | -48.34% | -18.88% | - | - | 1.19B | |
| +4.60% | +9.00% | -5.01% | -37.61% | -36.85% | +52.14% | +41.72% | +23.52% | +477.66% | 1.22B | |
| +2.69% | -4.75% | -2.67% | -8.03% | -13.76% | -10.89% | +14.25% | +74.35% | +59.38% | 1.03B | |
| +4.21% | -0.90% | -32.17% | -10.13% | +4.21% | -6.28% | +73.68% | -5.81% | - | 1.04B | |
| -0.79% | +3.58% | +1.48% | -17.12% | -20.15% | -37.01% | -73.60% | -81.27% | - | 923M | |
| -2.89% | +15.27% | -3.17% | -34.63% | -25.66% | +8.39% | +4.19% | -1.18% | +175.41% | 903M | |
| Average | +1.43% | +2.42% | -3.10% | -3.81% | +2.80% | +10.94% | +101.04% | +52.89% | +175.66% | 23.04B | |
| Weighted average by Cap. | +0.59% | -1.06% | -0.46% | +14.80% | +19.45% | +49.88% | +22.09% | +52.12% | +105.77% |
- Stock Market
- Stocks
- AB Stock
- A8D Stock
- Sector AB Science
Select your edition
All financial news and data tailored to specific country editions
